Cellex - Cell Expansion Devices srl

BioAxFlow technology presented here!

👉 InSyBio is a biotechnology company pioneering personalized healthcare and nutrition. Its mission focuses on developing frameworks and computational tools for analyzing complex life science and biological data. We are proud to share with InSyBio one of the most ambitious projects in our portfolio, OSTEONET, the Horizon project for the development of 3D in vitro cellular models of healthy and aged bone tissue to increase knowledge on the effects of aging on bone biology, mechanobiology, and bone response to drugs. 📍 Learn more about at the following link: https://lnkd.in/eVrB-AWz

🧬 Stem Cells (SCs) have the unique ability to self-renew and differentiate into many cell lineages. SCs represent an essential tool in Tissue Engineering because, according to the desired tissue, one can choose which SCs-type better suits the desired purpose. Cellex and their partner institutions are successfully cultivating human Mesenchymal Stem Cells (hMSCs) using BioAxFlow, which are commercially available multipotent stem cells differentiating into bone-tissue lineages for the OSTEONET project, aiming at generating bone constructs to treat osteoporosis. 👉 Stay tuned for more science pills!

✔️ By making scientific research more accessible, our bioreactor plays a crucial role in advancing scientific progress, economic growth, and social justice. Our easy-to-use bioreactor simplifies scientific research by making it more efficient and affordable, enabling cheaper and more effective medical and pharmaceutical solutions.

🧠 We firmly believe in the 'Dare to Think' philosophy of the Universiteit Gent, project partner and benchmark of our SME. The University of Ghent is an open, pluralistic, and socially committed university that conducts in-depth research in a wide range of scientific fields, including tissue engineering. 👉 With Ghent University, we work on the ambitious OSTEONET (Horizon Staff Exchange) project, which we invite you to learn more about at the following link: https://lnkd.in/eVrB-AWz

Crowlender ci aiuta nella crescita. Vuoi contribuire anche tu alla crescita di un mercato i cui rendimenti vanno dal 9.75% al 10.25% annuo lordo? Allora approfondisci leggendo il post! Grazie da tutti e tutte noi!

✔️ BioAxFlow simplifies research activities in multiple scientific fields. From Regenerative Medicine to Pharmaceutical Research, from the world of Nutraceuticals and Cosmeceuticals to the most advanced cell therapies, our tissue engineering bioreactor aims to support challenging projects by combining advanced technology and ease of use. 🔎 Learn more about Cellex's innovative bioreactor: 🖥️ https://lnkd.in/d8qQQpex ➡️ Get it on Sysmatech: https://lnkd.in/eAqQKpDB ➡️ Or contact us: https://lnkd.in/dkp6pP67

👉 The scientific community is increasingly focusing on bone tissue engineering. In this study, a cost-effective method for 3D printing of bone implants is proposed, using Poly Capro Lactone (PCL) and Poly Ethylen Glycol (PEG) for the rapid production of scaffolds with multiscale porosity. These scaffolds showed improved physical and biological properties comparable to those of more expensive methods. 📖 Read the study: https://lnkd.in/d8YwiFCZ

Thanks to Healthcare Industry Updates for including our company among the ones operating in the Cell Expansion market worldwide. This is quite an acknowledgment for us!

🧬 Bioprinting uses living cells, proteins, and nutrients as raw materials and has the potential to produce human tissues for treating injury and disease and to create entire organs for transplants. This technique might have the power of recreating tissues and organs thus, of being used in regenerative medicine or during 𝒊𝒏 𝒗𝒊𝒕𝒓𝒐 experiments that would benefit from having a real human-tissue model. 👉 Stay tuned for more science pills!